Clinical Trials Directory

Trials / Completed

CompletedNCT01682382

Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

Collection of Whole Blood Specimens and Buccal Swabs From Subjects Diagnosed With CNV AMD, Dry AMD, and Age-Matched Controls to Assess the Association of Genetic Variants in Complement Factor H With Risk of Progression to CNV.

Status
Completed
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
Sequenom, Inc. · Industry
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

Subjects with wet AMD, dry AMD, and age-matched controls will undergo routine occular measurements, will provide a blood and cheek cell sample, and will have macular pigment optical density (MPOD) measured to determine if there is an association between genetics, MPOD and the risk of progression to wet AMD.

Conditions

Timeline

Start date
2012-08-01
Primary completion
2013-08-01
Completion
2013-10-01
First posted
2012-09-10
Last updated
2014-01-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01682382. Inclusion in this directory is not an endorsement.